Award notice Supplies
Aquisição Centralizada de Medicamentos
Notice published in Portuguese. The AI analysis summarises it for you in your language.
- Public buyer
- Unidade Local de Saúde de São José, EPE
Lisboa - Place of performance
- Lisboa
- Estimated value
- €5,438,969 excl. VAT
- Amount awarded
- €5,438,969 excl. VAT
- Planned end of contract
- 31 December 2026
likely re-tender around October 2026 - Bids received
- 1
- Publication
- 7 August 2026
- Notice language
- Portuguese
AI analysis: go for it or not?
Summary in English, criteria, documents to provide and a GO / NO GO verdict in one minute.
Unlimited analyses during the 14-day Pro trial, no card needed.
Description
Aquisição Centralizada de Medicamentos
Awarded to
8 lots
- Lote 1 - IVACAFTOR 150 MG COMP
- Lote 2 - IVACAFTOR 75 MG + TEZACAFTOR 50 MG + ELEXACAFTOR 100 MG COMP
- Lote 3 - IVACAFTOR 75 MG COMP
- Lote 4 - IVACAFTOR 75 MG GRAN SAQ
- Lote 5 - IVACAFTOR 50 MG GRAN SAQ
- Lote 6 - IVACAFTOR 37.5 MG + TEZACAFTOR 25 MG + ELEXACAFTOR 50 MG COMP
- Lote 7 - LUMACAFTOR 100 MG + IVACAFTOR 125 MG GRAN SAQ
- Lote 8 - LUMACAFTOR 150 MG + IVACAFTOR 188 MG GRAN SAQ
CPV codes
European codes that classify what the contract is about. They are how we find the tenders for your trade.
33600000
Winning prices for comparable contracts
- A quarter below
- €247,856
- Median
- €358,774
- A quarter above
- €902,500
Amounts awarded (excl. VAT) over the last 3 years for 49 contracts in the same CPV group (3360…), excluding framework agreements. Half of the contracts fall between the two quartiles. TED source: mostly contracts above the EU thresholds, so amounts tend to be high.
Similar contracts already awarded
| Contract | Winner | Amount |
|---|---|---|
| Aquisição de UPADACITINIB 30 MG COMP LP e UPADACITINIB 45 MG COMP LP Unidade Local de Saúde de São José, EPE · 23 September 2026 |
ABBVIE,LDA | €429,048 |
| Amivantamab 50 mg/ml sol inj fr 7 ml iv Unidade Local de Saúde de São José, EPE · 9 September 2026 |
Janssen - Cilag Farmacêutica Lda | €394,934 |
| 41016726-Eptacog alfa (activado) 100 k.u.i. (2mg) e 250 k.u.i. (5mg) pó sol inj fr iv Unidade Local de Saúde de São José, EPE · 17 August 2026 |
Novo Nordisk, Lda | €1,161,008 |
| 41022526 - Aquisição de ivacaftor 75 mg + tezacaftor 50 mg + elexacaftor 100 mg gran saq Unidade Local de Saúde de São José, EPE · 7 August 2026 |
Vertex Pharmaceuticals (Portugal), Unipessoal Lda | €123,868 |
| 41012526 Nonacog beta pegol 1000UI pó sol inj fr IV e Nonacog Beta Pegol 2000 U.I. pó sol inj fr IV Unidade Local de Saúde de São José, EPE · 6 August 2026 |
Novo Nordisk, Lda | €770,296 |
Source : TED – Office des publications de l'Union européenne © Union européenne, données retraitées. Reference 548166-2026.